FindMyRecallSubscribe
Class I: serious health riskTerminated

Avet Pharmaceuticals Tetracycline HCL Capsules Recall

Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: H…

Avet Pharmaceuticals, Inc. · East Brunswick, NJ

Risk level
Class I
Reported by FDA
Apr 15, 2020
Recall ID
D-1254-2020
Check your lot numberHow we source this data

Summary

Avet Pharmaceuticals recalled Tetracycline HCL Capsules starting Mar 23, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1254-2020 on Apr 15, 2020. Reason: Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.

Product description

Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01

Lot numbers, UPCs & expiration codes

Lot #s: G190609, G190610, G190611, Exp Jun 2022: L191027, L191028, Exp Nov 2022: K190953, K190952, Exp Oct 2022

Where it was sold

Distributed Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1254-2020
Classification
Class I
Status
Terminated
Recall initiated
Mar 23, 2020
FDA report date
Apr 15, 2020
Quantity
17,524 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Avet Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1254-2020, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
85307
Address
1 Tower Center Blvd Ste 1700
Code information
Lot #s: G190609, G190610, G190611, Exp Jun 2022: L191027, L191028, Exp Nov 2022: K190953, K190952, Exp Oct 2022
Postal code
08816-1145
Report date
Apr 15, 2020
Product type
Drugs
Recall number
D-1254-2020
Classification
Class I
Recalling firm
Avet Pharmaceuticals, Inc.
Product quantity
17,524 bottles
Termination date
Aug 23, 2022
Reason for recall
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01
Distribution pattern
Distributed Nationwide in the US
Recall initiation date
Mar 23, 2020
Initial firm notification
Letter
Center classification date
Apr 27, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1254-2020, published Apr 15, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls